CWP
BIIB icon

Concord Wealth Partners’s Biogen BIIB Stock Holding History

Concord Wealth Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-114
Closed -$20.1K – 259
2025
Q4 		$20.1K Hold
114
– – ﹤0.01% 442
2025
Q3 		$16K Sell
114
-114
-50% -$15.4K ﹤0.01% 480
2025
Q2 		$28.6K Buy
228
+114
+100% +$14.2K ﹤0.01% 415
2025
Q1 		$15.6K Hold
114
– – ﹤0.01% 459
2024
Q4 		$17.4K Buy
114
+78
+217% +$13.2K ﹤0.01% 477
2024
Q3 		$6.98K Sell
36
-88
-71% -$18.4K ﹤0.01% 593
2024
Q2 		$28.7K Sell
124
-100
-45% -$21.7K 0.01% 376
2024
Q1 		$48.3K Sell
224
-533
-70% -$125K 0.01% 355
2023
Q4 		$196K Buy
757
+86
+13% +$21.1K 0.04% 198
2023
Q3 		$172K Buy
671
+557
+489% +$149K 0.04% 210
2023
Q2 		$32.5K Hold
114
– – 0.01% 421
2023
Q1 		$31.7K Sell
114
-3
-3% -$830 0.01% 415
2022
Q4 		$32.4K Buy
+117
New +$33K 0.01% 458
2022
Q3 		– Sell
-120
Closed -$24K – 259
2022
Q2 		$24K Sell
120
-120
-50% -$24.5K 0.01% 503
2022
Q1 		$51K Sell
240
-25
-9% -$5.44K 0.01% 433
2021
Q4 		$64K Buy
265
+241
+1,004% +$62K 0.02% 407
2021
Q3 		$7K Sell
24
-105
-81% -$34.4K ﹤0.01% 524
2021
Q2 		$45K Buy
129
+10
+8% +$3.03K 0.01% 369
2021
Q1 		$33K Sell
119
-225
-65% -$60.7K 0.01% 399
2020
Q4 		$84K Buy
+344
New +$88.7K 0.06% 147

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Concord Wealth Partners's BIIB Position: Q1 2026 in Review

Concord Wealth Partners sold out of Biogen (BIIB) in Q1 2026, closing a stake of 114 shares — an estimated $20.1K sold.

Concord Wealth Partners first reported a position in BIIB in Q4 2020 and held it in 20 quarters. The position peaked at $196K in Q4 2023. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Concord Wealth Partners reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
  • Concord Wealth Partners sold 114 Biogen shares in Q1 2026, an estimated $20.1K.
  • Concord Wealth Partners first reported a position in Biogen in Q4 2020 and held it in 20 quarters.
  • Concord Wealth Partners's Biogen position peaked at $196K in Q4 2023.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Concord Wealth Partners's 13F filing for Q1 2026, filed 1 May 2026.